TerrAscend Corp.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Ziad Ghanem
- Full Time Employees
- 1,038
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- 77 City Centre Drive, East Tower Mississauga ON Canada L5B 1M5
- IPO Date
- May 3, 2017
- Website
- terrascend.com
- Similar Companies
- Business
- TerrAscend Corp. is a prominent North American cannabis operator, actively engaged in the cultivation, processing, and distribution of cannabis products across key markets in the United States and Canada. The company manages vertically integrated operations spanning California, Maryland, New Jersey, Ohio, and Pennsylvania, complemented by retail presence in Canada. Its diverse product portfolio caters to both medical and adult-use consumers, featuring offerings such as flower, vaporizables, concentrates, tinctures, topicals, and edibles. Operating a network of retail dispensaries, including the acclaimed Apothecarium brand, TerrAscend emphasizes consistent quality and patient education. The company strategically manages an array of synergistic brands and businesses, among them Gage Cannabis, Kind Tree, Legend, Valhalla Confections, State Flower, Ilera Healthcare, Wana, Cookies, Lemonnade, and Ratio Cannabis. Recent strategic initiatives include expanding its footprint in emerging markets like Ohio through acquisitions, and bolstering its presence in New Jersey. TerrAscend has demonstrated consistent financial strength, reporting positive operating cash flow for thirteen consecutive quarters. The company, founded in 2017, is headquartered in Mississauga, Canada, with operational offices in King of Prussia, Pennsylvania.
Company News
TerrAscend to Host Third Quarter 2026 Earnings Conference Call
Critical Survey: TerrAscend (OTCMKTS:TSNDF) versus Milestone Scientific (NYSE:MLSS)
TSNDF Stock Rises 6.5% in a Month: Time to Buy, Hold or Sell?
TerrAscend to Participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference
TerrAscend Announces Results of Special Meeting of Shareholders
TerrAscend Corp. (TSND:CA) Shareholder/Analyst Call Prepared Remarks Transcript
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
TerrAscend to Host Second Quarter 2026 Earnings Conference Call
TerrAscend Signs Agreement to Acquire Fifth Dispensary in New Jersey
TerrAscend Files Preliminary Proxy Statement for Special Meeting of Shareholders in Preparation for Uplisting to US Exchange
TerrAscend Completes Oversubscribed Debt Financing, Raising $21.7 Million
TerrAscend Announces Results of Annual General Meeting
TerrAscend Corp. (TSND:CA) Shareholder/Analyst Call Prepared Remarks Transcript
TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting
TerrAscend Reports First Quarter 2026 Financial Results
TerrAscend Reports First Quarter 2026 Financial Results
TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call
TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call
TerrAscend (OTCMKTS:TSNDF) Trading 4% Higher – What’s Next?
TerrAscend (OTCMKTS:TSNDF) and Phibro Animal Health (NASDAQ:PAHC) Head to Head Analysis